BCL7A anticorps (C-Term)
-
- Antigène Voir toutes BCL7A Anticorps
- BCL7A (B-Cell CLL/lymphoma 7A (BCL7A))
-
Épitope
- C-Term
-
Reactivité
- Humain, Souris, Rat, Boeuf (Vache), Chien, Porc
-
Hôte
- Chèvre
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp BCL7A est non-conjugé
-
Application
- Western Blotting (WB)
- Séquence
- C-MKLEASQQNS EEM
- Specificité
- This antibody detects Bcl-7A at C-term.
- Purification
- Ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide
- Immunogène
- Peptide from C Terminus of the protein Genename: BCL7A
- Top Product
- Discover our top product BCL7A Anticorps primaire
-
-
- Indications d'application
-
Western Blot: 0.5-2 μg/mL. Approx 35 kDa band seen in HeLa cell lysates.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user. - Restrictions
- For Research Use only
-
- Concentration
- 0.5 mg/mL
- Buffer
- Tris saline, 0.02 % sodium azide, pH 7.3 with 0.5 % bovine serum albumin
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Conseil sur la manipulation
- Avoid repeated freezing and thawing.
- Stock
- 4 °C/-20 °C
- Stockage commentaire
- Store the antibody at 2 - 8 °C up to one month or (in aliquots) at -20 °C for longer.
-
- Antigène
- BCL7A (B-Cell CLL/lymphoma 7A (BCL7A))
- Autre désignation
- Bcl-7A (BCL7A Produits)
- Synonymes
- anticorps BCL7, anticorps cb585, anticorps id:ibd1097, anticorps sb:cb585, anticorps wu:fk02d01, anticorps zgc:92023, anticorps 4432415N06Rik, anticorps AI448316, anticorps bcl7a, anticorps MGC89576, anticorps BCL7A, anticorps BCL tumor suppressor 7A, anticorps B-cell CLL/lymphoma 7A, anticorps B cell CLL/lymphoma 7A, anticorps B-cell CLL/lymphoma 7A L homeolog, anticorps BCL7A, anticorps bcl7a, anticorps Bcl7a, anticorps bcl7a.L
- Sujet
- This gene is directly involved, with Myc and IgH, in a three-way gene translocation in a Burkitt lymphoma cell line. As a result of the gene translocation, the N-terminal region of the gene product is disrupted, which is thought to be related to the pathogenesis of a subset of high-grade B cell non-Hodgkin lymphoma. The N-terminal segment involved in the translocation includes the region that shares a strong sequence similarity with those of BCL7B and BCL7C.Synonyms: B-cell CLL/lymphoma 7 protein family member A, BCL7A
- ID gène
- 605
- NCBI Accession
- NP_066273
- UniProt
- Q4VC05
-